Skip to main content
Journal cover image

HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES

Conferences
Wyatt, B; Abraham, SV; Dinani, A; Mageras, A; Miller, M; Harty, AL; Perumalswami, PV; Vandromme, M; Branch, AD
Published in: HEPATOLOGY
November 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

November 2020

Volume

72

Start / End Page

559A / 559A

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wyatt, B., Abraham, S. V., Dinani, A., Mageras, A., Miller, M., Harty, A. L., … Branch, A. D. (2020). HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. In HEPATOLOGY (Vol. 72, pp. 559A-559A).
Wyatt, Brooke, Sherley V. Abraham, Amreen Dinani, Anna Mageras, Mark Miller, Alyson L. Harty, Ponni V. Perumalswami, Maxence Vandromme, and Andrea D. Branch. “HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES.” In HEPATOLOGY, 72:559A-559A, 2020.
Wyatt B, Abraham SV, Dinani A, Mageras A, Miller M, Harty AL, et al. HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. In: HEPATOLOGY. 2020. p. 559A-559A.
Wyatt, Brooke, et al. “HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES.” HEPATOLOGY, vol. 72, 2020, pp. 559A-559A.
Wyatt B, Abraham SV, Dinani A, Mageras A, Miller M, Harty AL, Perumalswami PV, Vandromme M, Branch AD. HCV CURE LEADS TO IMPROVEMENTS IN TYPE 2 DIABETES. HEPATOLOGY. 2020. p. 559A-559A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

November 2020

Volume

72

Start / End Page

559A / 559A

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences